| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |